growing prevalence of cancer cases is driving the Cancer Supportive Care Market

Latest News:- Cancer Supportive Care Market: Chemotherapy-induced anemia is expected to lead the Therapeutic Area segment during 2024-2028

Technavio analyzes that the Cancer Supportive Care Market is expected to grow at a CAGR of 4.3% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 6259.3 million.There are various factors that contribute to the growth of the market. The cancer supportive care market is experiencing significant growth due to the increasing prevalence of cancer cases worldwide. According to the World Health Organization, there will be approximately 19.3 million new cancer cases and nearly 10.0 million cancer deaths in 2020. This rising incidence of cancer necessitates comprehensive and effective supportive care services to improve patients' quality of life and manage symptoms. The market for cancer supportive care is anticipated to expand in response to this growing demand.

Anemia, a prevalent condition characterized by insufficient healthy red blood cells or hemoglobin, is a significant challenge in childhood cancer patients undergoing oncology treatment. With chemotherapy being a common therapy, approximately 100% of patients experience mild anemia, and over 75% develop severe symptoms. Hemoglobin, a major component of red blood cells responsible for oxygen binding, becomes deficient, leading to fatigue and impaired organ function due to insufficient oxygen supply. Targeted molecule therapies and opioids are essential tools in managing severe anemia symptoms, mitigating the public health crisis caused by this debilitating side effect. 

Know which region is leading the market growth by requesting a sample report

Cancer Supportive Care Market Segmentation

• Therapeutic Area
  • Chemotherapy-induced anemia
  • Chemotherapy-induced neutropenia
  • Cancer pain
  • CINV
  • Others
• Distribution Channel
  • Hospitals pharmacies
  • Drug stores and retail pharmacies
  • Online providers
• Geography
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

• Amgen Inc.
• Baxter International Inc.
• Bayer AG
• Daiichi Sankyo Co. Ltd.
• Eli Lilly and Co.
• F. Hoffmann La Roche Ltd.
• GlaxoSmithKline Plc
• Helsinn Healthcare SA
• Heron Therapeutics Inc.
• Johnson and Johnson Services Inc.
• Kyowa Kirin Co. Ltd.
• Merck and Co. Inc.
• Novartis AG
• Pfizer Inc.
• Purdue Pharma LP
• RELIEF THERAPEUTICS Holding SA
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Cancer Supportive Care Market encompasses various treatments and interventions to manage adverse effects and toxicities of cancer therapies, including Granulocyte colony-stimulating factors and antiemetics. Breast cancer patients in hospitals and online pharmacies receive supportive care during post-therapy, addressing chemotherapy-induced side effects such as anemia, hair loss, and pain. Healthcare administration, palliative care specialists, and pain care specialists collaborate in patient-centric care. Drug development in pharmaceuticals advances innovative therapies like erythropoiesis-stimulating agents (ESAs) and antibody-drug combinations for metastatic colorectal cancer, anemia, and triple-negative breast cancer. The aging and geriatric population's increasing cancer prevalence necessitates personalized medicine, biosimilars, and generic medications to improve accessibility and affordability. Cancer treatment toxicities are addressed through clinical trials and the development of new supportive care strategies.

Market Research Overview

The Cancer Supportive Care Market is a significant segment of the global Healthcare Equipment Market, according to Technavio's market research. This market encompasses companies and products dedicated to the research and development (R&D) of antiemetics and other supportive care solutions for breast cancer patients. The parent Healthcare Equipment Market entails manufacturers of various diagnostic equipment and devices, including capital equipment, instruments, implants, accessories, and consumables, used for disease diagnosis, monitoring, and treatment. Technavio calculates the market size based on the combined revenue generated by these manufacturers across therapy areas. The Healthcare Equipment Industry consists of Devices, which include advanced, differentiated, and clinically tested data-driven devices, essential for cancer supportive care.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

• Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.


• Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.


• High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/